Funded Tech Companies
Diasome Pharmaceuticals
Diasome Pharmaceuticals, based in Cleveland, received equity investments through Medicxi Ventures, private investors and JDRF T1D Fund.
Company Overview
Company Name
Diasome Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
10000 Cedar Ave. 6
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Company Background Information
Overview
Diasome Pharmaceuticals, Inc. is a venture-backed biopharmaceutical company focused on novel insulin-based therapies for the improved treatment of diabetes. The Company was formed in 2004 and has completed multiple Phase II human studies of HDV-Insulin, its proprietary insulin targeting system.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/6/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Geho
Chief Financial Officer
Helga Kautsky
Chief Scientific Officer
Blair Geho
Company Investors
- Medicxi Ventures (Michele Ollier)
- JDRF T1D Fund
- Black Beret Life Sciences
- BioAdvance Ventures
- Devon Park Bioventures (Devang Kantesaria)
- Quaker Partners (Brenda Gavin)
Browse more funded tech companies:
Diartis Pharmaceuticals | DiaTech
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs